Cite Filings / INAB
Feed Companies Filings Check
Sign in

CIK 0001740279

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

IN8BIO, INC.

Sign in to watch
Ticker
INAB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
825462585
Phone
+1 646-600-6438
Business address
EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, NEW YORK, NY, 10118
Former names
Incysus Therapeutics, Inc.
Filings Financials Insiders Search text
All 412 Financials 100 Shareholder Meetings 6 Executive Compensation 88 Insider Trading 185 Beneficial Ownership Interest 32 Business Combinations 77 Public Offerings 48 Mutual Funds and ETFs 5 Others 46
›
Filed in
  1. No filings match these filters. Clear filters
  2. CORRESP Other Correspondence Between Filers and SEC Staff 2020-11-16
  3. CORRESP Other Correspondence Between Filers and SEC Staff 2020-11-16
  4. CORRESP Other Correspondence Between Filers and SEC Staff 2020-11-09
  5. CORRESP Other Correspondence Between Filers and SEC Staff 2020-11-09
  6. S-1/A Offering Registration Statement 2020-11-05
  7. CORRESP Other Correspondence Between Filers and SEC Staff 2020-10-27
  8. S-1 Offering Registration Statement 2020-10-16
  9. UPLOAD Other SEC-generated Letter 2020-10-07

Page 3 of 3 · 48 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…